I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

InterCure Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InterCure Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
I
InterCure Ltd
TASE:INCR
Cash Equivalents
â‚Ş101.1m
CAGR 3-Years
39%
CAGR 5-Years
97%
CAGR 10-Years
63%
Teva Pharmaceutical Industries Ltd
TASE:TEVA
Cash Equivalents
$2.3B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
9%
Sol Gel Technologies Ltd
NASDAQ:SLGL
Cash Equivalents
$13.4m
CAGR 3-Years
-32%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Mediwound Ltd
NASDAQ:MDWD
Cash Equivalents
$3.8m
CAGR 3-Years
-40%
CAGR 5-Years
-31%
CAGR 10-Years
-16%
S
Seach Medical Group Ltd
TASE:SEMG
Cash Equivalents
â‚Ş8.2m
CAGR 3-Years
-24%
CAGR 5-Years
3%
CAGR 10-Years
57%
R
Rekah Pharmaceutical Industry Ltd
TASE:REKA
Cash Equivalents
â‚Ş5.4m
CAGR 3-Years
-48%
CAGR 5-Years
-33%
CAGR 10-Years
-11%
No Stocks Found

InterCure Ltd
Glance View

Market Cap
239.6m ILS
Industry
Pharmaceuticals

InterCure Ltd. engages in the business of medical cannabis and biomedicine. Thorugh its wholly owned subsidiary Canndoc the Company operates as licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products.

INCR Intrinsic Value
1 796.79 ILS
Undervaluation 72%
Intrinsic Value
Price
I

See Also

What is InterCure Ltd's Cash Equivalents?
Cash Equivalents
101.1m ILS

Based on the financial report for Dec 31, 2023, InterCure Ltd's Cash Equivalents amounts to 101.1m ILS.

What is InterCure Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
63%

Over the last year, the Cash Equivalents growth was -57%. The average annual Cash Equivalents growth rates for InterCure Ltd have been 39% over the past three years , 97% over the past five years , and 63% over the past ten years .

Back to Top